Published in Psychiatry Res on May 21, 2010
Efficacy of cognitive behavioural therapy for sleep improvement in patients with persistent delusions and hallucinations (BEST): a prospective, assessor-blind, randomised controlled pilot trial. Lancet Psychiatry (2015) 1.97
Insomnia comorbid to severe psychiatric illness. Sleep Med Clin (2013) 0.85
Eszopiclone treatment for insomnia: effect size comparisons in patients with primary insomnia and insomnia with medical and psychiatric comorbidity. Prim Care Companion CNS Disord (2012) 0.81
Genome-wide association analyses of sleep disturbance traits identify new loci and highlight shared genetics with neuropsychiatric and metabolic traits. Nat Genet (2016) 0.79
The prevalence and management of poor sleep quality in a secondary care mental health population. J Clin Sleep Med (2015) 0.77
Perspectives on Sleep, Sleep Problems, and Their Treatment, in People with Serious Mental Illnesses: A Systematic Review. PLoS One (2016) 0.76
Schizophrenia and sleep disorders: links, risks, and management challenges. Nat Sci Sleep (2017) 0.75
Clozapine alone versus clozapine and risperidone with refractory schizophrenia. N Engl J Med (2006) 4.16
Inflammatory cytokine alterations in schizophrenia: a systematic quantitative review. Biol Psychiatry (2007) 3.22
Selective serotonin reuptake inhibitor (SSRI) add-on therapy for the negative symptoms of schizophrenia: a meta-analysis. J Clin Psychiatry (2007) 2.13
The crossover approach to switching antipsychotics: what is the evidence? Schizophr Res (2005) 1.55
Attenuation of post-myocardial infarction depression in rats by n-3 fatty acids or probiotics starting after the onset of reperfusion. Br J Nutr (2012) 1.53
Preserved awareness of their cognitive deficits in patients with schizophrenia: convergent validity of the SSTICS. Schizophr Res (2008) 1.48
Comparing tolerability of olanzapine in schizophrenia and affective disorders: a meta-analysis. Drug Saf (2012) 1.42
Sleep in untreated patients with schizophrenia: a meta-analysis. Schizophr Bull (2004) 1.31
Atypical sleep architecture and the autism phenotype. Brain (2005) 1.28
Should we treat auditory hallucinations with repetitive transcranial magnetic stimulation? A metaanalysis. Can J Psychiatry (2008) 1.09
Assessment of executive dysfunction during activities of daily living in schizophrenia. Schizophr Res (2004) 1.07
A randomized, double-blind, placebo-controlled study of the safety and tolerability of high-dose quetiapine in patients with persistent symptoms of schizophrenia or schizoaffective disorder. J Clin Psychiatry (2011) 1.06
Are metabolic indices different between drug-naïve first-episode psychosis patients and healthy controls? Schizophr Res (2008) 1.06
Self-assessed cognitive dysfunction and objective performance in outpatients with schizophrenia participating in a rehabilitation program. Schizophr Res (2004) 1.04
Cognitive predictors of psychosocial functioning outcome in schizophrenia: a follow-up study of subjects participating in a rehabilitation program. Schizophr Res (2005) 1.04
Computerized assessment of cognition in schizophrenia: promises and pitfalls of CANTAB. Eur Psychiatry (2007) 1.01
Cerebral activity associated with auditory verbal hallucinations: a functional magnetic resonance imaging case study. J Psychiatry Neurosci (2002) 1.01
On the trail of a cognitive enhancer for the treatment of schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry (2005) 1.01
CANTAB explicit memory is less impaired in addicted schizophrenia patients. Brain Cogn (2005) 1.00
Oral versus Long-Acting Injectable Antipsychotics in the Treatment of Schizophrenia and Special Populations at Risk for Treatment Nonadherence: A Systematic Review. Schizophr Res Treatment (2012) 1.00
Predictors of quality of life in schizophrenia. Community Ment Health J (2005) 1.00
Combination of Lactobacillus helveticus R0052 and Bifidobacterium longum R0175 reduces post-myocardial infarction depression symptoms and restores intestinal permeability in a rat model. Br J Nutr (2011) 1.00
Changes in serum lipids, independent of weight, are associated with changes in symptoms during long-term clozapine treatment. J Psychiatry Neurosci (2007) 0.99
Contradictory cognitive capacities among substance-abusing patients with schizophrenia: a meta-analysis. Schizophr Res (2007) 0.98
Sleep architecture and its clinical correlates in first episode and neuroleptic-naive patients with schizophrenia. Schizophr Res (2003) 0.98
Effects of cognitive remediation therapies on psychotic symptoms and cognitive complaints in patients with schizophrenia and related disorders: a randomized study. Schizophr Res (2009) 0.97
Enhanced connectivity between visual cortex and other regions of the brain in autism: a REM sleep EEG coherence study. Autism Res (2010) 0.96
Antipsychotic-induced parkinsonism is associated with working memory deficits in schizophrenia-spectrum disorders. Eur Arch Psychiatry Clin Neurosci (2014) 0.95
The effect of quetiapine on cannabis use in 8 psychosis patients with drug dependency. Can J Psychiatry (2004) 0.94
Benefits and risks of antipsychotic polypharmacy: an evidence-based review of the literature. Drug Saf (2008) 0.93
Effects of gestational stress: 1. Evaluation of maternal and juvenile offspring behavior. Brain Res (2008) 0.93
Brain activity during emotionally negative pictures in schizophrenia with and without flat affect: an fMRI study. Psychiatry Res (2005) 0.92
Procedural learning in schizophrenia after 6 months of double-blind treatment with olanzapine, risperidone, and haloperidol. Psychopharmacology (Berl) (2003) 0.92
Apoptosis detected in the amygdala following myocardial infarction in the rat. Biol Psychiatry (2005) 0.92
Pain perception in schizophrenia: no changes in diffuse noxious inhibitory controls (DNIC) but a lack of pain sensitization. J Psychiatr Res (2008) 0.90
ERP investigation of study-test background mismatch during face recognition in schizophrenia. Schizophr Res (2011) 0.89
Dream content in chronically-treated persons with schizophrenia. Schizophr Res (2009) 0.89
Vulnerability for apoptosis in the limbic system after myocardial infarction in rats: a possible model for human postinfarct major depression. J Psychiatry Neurosci (2007) 0.89
Sexual dimorphism in schizophrenia: is there a need for gender-based protocols? Expert Rev Neurother (2011) 0.89
Rivastigmine treatment as an add-on to antipsychotics in patients with schizophrenia and cognitive deficits. Curr Med Res Opin (2007) 0.89
Pain perception in schizophrenia: evidence of a specific pain response profile. Pain Med (2012) 0.88
Treating delusional disorder: a comparison of cognitive-behavioural therapy and attention placebo control. Can J Psychiatry (2007) 0.88
Dose-response and comparative efficacy and tolerability of quetiapine across psychiatric disorders: a systematic review of the placebo-controlled monotherapy and add-on trials. Int Clin Psychopharmacol (2011) 0.88
EEG spectral analysis of wakefulness and REM sleep in high functioning autistic spectrum disorders. Clin Neurophysiol (2004) 0.88
Melatonin for disordered sleep in individuals with autism spectrum disorders: systematic review and discussion. Sleep Med Rev (2011) 0.87
Neural correlates of emotional recognition memory in schizophrenia: effects of valence and arousal. Psychiatry Res (2011) 0.87
Could the use of energy drinks induce manic or depressive relapse among abstinent substance use disorder patients with comorbid bipolar spectrum disorder? Bipolar Disord (2011) 0.87
Differential hemodynamic brain activity in schizophrenia patients with blunted affect during quetiapine treatment. J Clin Psychopharmacol (2005) 0.87
Agenesis of corpus callosum and emotional information processing in schizophrenia. Front Psychiatry (2012) 0.87
An Exploratory, Open-Label, Randomized Trial Comparing Risperidone Long-Acting Injectable with Oral Antipsychotic Medication in the Treatment of Early Psychosis. Clin Schizophr Relat Psychoses (2013) 0.86
Lactobacillus helveticus and Bifidobacterium longum taken in combination reduce the apoptosis propensity in the limbic system after myocardial infarction in a rat model. Br J Nutr (2009) 0.86
Pretreatment with pentoxifylline has antidepressant-like effects in a rat model of acute myocardial infarction. Behav Pharmacol (2011) 0.86
Sensation-seeking, social anhedonia, and impulsivity in substance use disorder patients with and without schizophrenia and in non-abusing schizophrenia patients. Psychiatry Res (2012) 0.85
A study of theory of mind in paranoid schizophrenia: a theory or many theories? Front Psychol (2012) 0.85
[Developing better practices]. Sante Ment Que (2003) 0.85
Attention and non-REM sleep in neuroleptic-naive persons with schizophrenia and control participants. Psychiatry Res (2006) 0.85
Daily activities, cognition and community functioning in persons with schizophrenia. Schizophr Res (2008) 0.85
Substance abuse is associated with increased extrapyramidal symptoms in schizophrenia: a meta-analysis. Schizophr Res (2009) 0.85
Escitalopram reduces circulating pro-inflammatory cytokines and improves depressive behavior without affecting sleep in a rat model of post-cardiac infarct depression. Behav Brain Res (2011) 0.85
Add-on therapy with acetylcholinesterase inhibitors for memory dysfunction in schizophrenia: a systematic quantitative review, part 2. Clin Neuropharmacol (2007) 0.85
Endogenous cannabinoids in patients with schizophrenia and substance use disorder during quetiapine therapy. J Psychopharmacol (2008) 0.84
Memory and executive functions in adults with Gilles de la Tourette syndrome and chronic tic disorder. Cogn Neuropsychiatry (2007) 0.84
The incidence and nature of cerebellar findings in schizophrenia: a quantitative review of fMRI literature. Schizophr Bull (2012) 0.84
Use of the process dissociation procedure to study the contextual effects on face recognition in schizophrenia: familiarity, associative recollection and discriminative recollection. Psychiatry Res (2006) 0.84
The crucial role of sustained attention in community functioning in outpatients with schizophrenia. Psychiatry Res (2004) 0.84
Do patients with schizophrenia attribute mental states in a referential communication task? Cogn Neuropsychiatry (2009) 0.84
Relationship between psychotic and obsessive compulsive symptoms in schizophrenia. Schizophr Res (2009) 0.84
Processing of social emotion in patients with schizophrenia and substance use disorder: an fMRI study. Soc Neurosci (2007) 0.83
Mild procedural learning disturbances in neuroleptic-naive patients with schizophrenia. J Neuropsychiatry Clin Neurosci (2003) 0.83
Celecoxib after the onset of reperfusion reduces apoptosis in the amygdala. Apoptosis (2007) 0.83
Sex differences in the cerebral function associated with processing of aversive stimuli by schizophrenia patients. Aust N Z J Psychiatry (2007) 0.82
Procedural learning in schizophrenia can reflect the pharmacologic properties of the antipsychotic treatments. Cogn Behav Neurol (2004) 0.82
Antipsychotic agents for the treatment of substance use disorders in patients with and without comorbid psychosis. J Clin Psychopharmacol (2010) 0.82
Genealogy of instruments for prodrome evaluation of psychosis. Front Psychiatry (2013) 0.82
Paradoxical sleep insomnia and decreased cholinergic neurons after myocardial infarction in rats. Sleep (2010) 0.82
Weight gain and lipid metabolic abnormalities induced by olanzapine in first-episode, drug-naïve patients with psychotic disorders. Schizophr Res (2005) 0.82
Electrophysiological manifestations of stimulus evaluation, response inhibition and motor processing in Tourette syndrome patients. Psychiatry Res (2009) 0.82
[The role of social support, family burden and satisfaction with services in psychological distress and quality of life of families of individuals with schizophrenia]. Sante Ment Que (2005) 0.82
The effects of early and late night partial sleep deprivation on automatic and selective attention: An ERP study. Brain Res (2009) 0.81
Extrapyramidal symptoms in substance abusers with and without schizophrenia and in nonabusing patients with schizophrenia. Mov Disord (2010) 0.81
The cognitive and anatomo-functional basis of reality distortion in schizophrenia: a view from memory event-related potentials. Psychiatry Res (2003) 0.81
Language functions in right-hemisphere damage and schizophrenia: apparently similar pragmatic deficits may hide profound differences. Brain (2007) 0.81
Comparing tolerability profile of quetiapine, risperidone, aripiprazole and ziprasidone in schizophrenia and affective disorders: a meta-analysis. Expert Opin Drug Saf (2012) 0.81
Anhedonia and social adaptation predict substance abuse evolution in dual diagnosis schizophrenia. Am J Drug Alcohol Abuse (2008) 0.81
Quetiapine in patients with comorbid schizophrenia-spectrum and substance use disorders: an open-label trial. Curr Med Res Opin (2006) 0.81
Increased striatal gray matter densities in patients with schizophrenia and substance use disorder: a voxel-based morphometry study. Psychiatry Res (2007) 0.81
Sexual dimorphism of spatial working memory profiles in schizophrenia. Cogn Neuropsychiatry (2010) 0.81
Meta-analysis of depressive symptoms in dual-diagnosis schizophrenia. Aust N Z J Psychiatry (2007) 0.80
Brain-behavior relations during motor processing in chronic tic and habit disorder. Cogn Behav Neurol (2005) 0.80